METHYLDRENE ORIGINAL BY CLOMA PHARMA
Methyldrene is the super-effective plant-based ECA stack with Eph and Hoodia! Methyldrene is the proven ECA stack and a whole lot more! If you want a potent, and very strong eph product then Methyldrene is for you!
Methyldrene is the scientific breakthrough in rapid weight loss! When Methyldrene is taken before a physical activity, it gives an extra boost of energy to the body allowing for increased endurance. Try Methyldrene today and see the weight loss results and energizing vitality that only Methyldrene is capable of giving you! Methyldrene will help you burn it off and keep it off.
When used as part of a weight loss plan that incorporated a reduced caloric intake and increased physical activity, it is guaranteed to be a valuable adjunct to your weight loss plan.
For Best Results: Eat 5-6 smaller meals per day – Reduce daily carbohydrate intake – Eliminate fast food and soda from your diet
Serving Size: 1 Capsule
Servings per Container: 100
Vitamin B6 2mg 100%
Vitamin B12 6mcg 100%
Chromium Picolinate 30mcg 25%
ECA Proprietary Blend 375mg *
Caffeine Anhydrous 250mg *
White Willow Bark Powder (25% Salicins) 100mg *
E Viridis leaf 25mg *
Methyldrene Fat-Burning Support System 397mg *
Citrus Aurantium Extract (Fruit)(30% Synephrine), Panax Ginseng Extract (Root)(4% Ginsenosides), Ginger Root, Hoodia Gordonii (Opuntia Stricta Var Dilleni) 20:1 Stem Extract, Cayenne Fruit 40,000 Heat Units, Green Tea Leaf (95% Polyphenols), Cocoa Bean Extract (20% Theobromine), Yohimbe Bark Extract (8% Yohimbine), Griffonia Seed Standardized Extract (Source of 5-HTP)
*Daily Value not established
Other Ingredients: Gelatin, Magnesium Stearate, Silicon Dioxide, FD&C Yellow #5
Directions: As a dietary supplement, take one capsule in the morning with breakfast and one capsules in the afternoon with lunch. Do not exceed two capsules within any 24-hour period. Do not take within 6 hours of sleep.
Out of stock
Only logged in customers who have purchased this product may leave a review.
There are no reviews yet.